BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND TMEM127, FLJ20507, 55654, ENSG00000135956, O75204, FLJ22257
76 results:

  • 1. Loss of tumor suppressor tmem127 drives RET-mediated transformation through disrupted membrane dynamics.
    Walker TJ; Reyes-Alvarez E; Hyndman BD; Sugiyama MG; Oliveira LCB; Rekab AN; Crupi MJF; Cabral-Dias R; Guo Q; Dahia PLM; Richardson DS; Antonescu CN; Mulligan LM
    Elife; 2024 Apr; 12():. PubMed ID: 38687678
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. tmem127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation.
    Guo Q; Cheng ZM; Gonzalez-Cantú H; Rotondi M; Huelgas-Morales G; Ethiraj P; Qiu Z; Lefkowitz J; Song W; Landry BN; Lopez H; Estrada-Zuniga CM; Goyal S; Khan MA; Walker TJ; Wang E; Li F; Ding Y; Mulligan LM; Aguiar RCT; Dahia PLM
    Cell Rep; 2023 Sep; 42(9):113070. PubMed ID: 37659079
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Bilateral pheochromocytoma associates with tmem127 gene mutation. Report of one case].
    Delgado JF; Pérez E MJ; Delgado D; Lagos C; Baudrand R; Uslar T
    Rev Med Chil; 2022 Aug; 150(8):1115-1118. PubMed ID: 37358160
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Case Report: Composite pheochromocytoma with ganglioneuroma component: A report of three cases.
    Araujo PB; Carvallo MS; Vidal AP; Nascimento JB; Wo JM; Naliato EO; Cunha Neto SH; Conceição FL; Fontes R; de Lima VV; Carvalho DP; Soares P; Lima J; Lourenço DM; Violante AHD
    Front Endocrinol (Lausanne); 2022; 13():903085. PubMed ID: 36187102
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Novel Germline
    Provenzano A; Chetta M; De Filpo G; Cantini G; La Barbera A; Nesi G; Santi R; Martinelli S; Rapizzi E; Luconi M; Maggi M; Mannelli M; Ercolino T; Canu L
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013579
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield.
    Horton C; LaDuca H; Deckman A; Durda K; Jackson M; Richardson ME; Tian Y; Yussuf A; Jasperson K; Else T
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1917-e1923. PubMed ID: 35026032
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetics of pheochromocytoma and paraganglioma.
    Wachtel H; Fishbein L
    Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):283-290. PubMed ID: 33764930
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study.
    Ma X; Li M; Tong A; Wang F; Cui Y; Zhang X; Zhang Y; Chen S; Li Y
    Front Endocrinol (Lausanne); 2020; 11():574662. PubMed ID: 33362715
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients.
    Yamazaki Y; Gao X; Pecori A; Nakamura Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Satoh F; Sasano H
    Front Endocrinol (Lausanne); 2020; 11():587769. PubMed ID: 33193100
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genotype-Phenotype Features of Germline Variants of the tmem127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.
    Armaiz-Pena G; Flores SK; Cheng ZM; Zhang X; Esquivel E; Poullard N; Vaidyanathan A; Liu Q; Michalek J; Santillan-Gomez AA; Liss M; Ahmadi S; Katselnik D; Maldonado E; Salgado SA; Jimenez C; Fishbein L; Hamidi O; Else T; Lechan R; Tischler AS; Benn DE; Dwight T; Clifton-Bligh R; Sanso G; Barontini M; Vincent D; Aronin N; Biondi B; Koops M; Bowhay-Carnes E; Gimenez-Roqueplo AP; Alvarez-Eslava A; Bruder JM; Kitano M; Burnichon N; Ding Y; Dahia PLM
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e350-e364. PubMed ID: 33051659
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Functional Characterization of tmem127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking.
    Flores SK; Deng Y; Cheng Z; Zhang X; Tao S; Saliba A; Chu I; Burnichon N; Gimenez-Roqueplo AP; Wang E; Aguiar RCT; Dahia PLM
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3142-56. PubMed ID: 32575117
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
    Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma.
    Muth A; Crona J; Gimm O; Elmgren A; Filipsson K; Stenmark Askmalm M; Sandstedt J; Tengvar M; Tham E
    J Intern Med; 2019 Feb; 285(2):187-204. PubMed ID: 30536464
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Genetics of pheochromocytoma and the relevance in surgery].
    von Dobschütz E; Neumann HPH
    Chirurg; 2019 Jan; 90(1):15-22. PubMed ID: 30306232
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].
    Vermalle M; Tabarin A; Castinetti F
    Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S10-S21. PubMed ID: 30213301
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The tmem127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex.
    Deng Y; Qin Y; Srikantan S; Luo A; Cheng ZM; Flores SK; Vogel KS; Wang E; Dahia PLM
    Hum Mol Genet; 2018 May; 27(10):1794-1808. PubMed ID: 29547888
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis.
    Lussey-Lepoutre C; Buffet A; Morin A; Goncalves J; Favier J
    Cell Tissue Res; 2018 May; 372(2):379-392. PubMed ID: 29427052
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Homozygous tmem127 mutations in 2 patients with bilateral pheochromocytomas.
    Eijkelenkamp K; Olderode-Berends MJW; van der Luijt RB; Robledo M; van Dooren M; Feelders RA; de Vries J; Kerstens MN; Links TP; van der Horst-Schrivers ANA
    Clin Genet; 2018 May; 93(5):1049-1056. PubMed ID: 29282712
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.
    Casey RT; Warren AY; Martin JE; Challis BG; Rattenberry E; Whitworth J; Andrews KA; Roberts T; Clark GR; West H; Smith PS; Docquier FM; Rodger F; Murray V; Simpson HL; Wallis Y; Giger O; Tran M; Tomkins S; Stewart GD; Park SM; Woodward ER; Maher ER
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4013-4022. PubMed ID: 28973655
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (tmem127).
    Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.